Intratumoral and intertumoral heterogeneity drives EGFR treatment considerations
J Thorac Dis
.
2022 May;14(5):1299-1301.
doi: 10.21037/jtd-22-312.
Authors
Kevin Lu
1
,
Hatim Husain
2
Affiliations
1
University of California, San Diego, La Jolla, CA, USA.
2
Division of Hematology and Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
PMID:
35693600
PMCID:
PMC9186249
DOI:
10.21037/jtd-22-312
No abstract available
Publication types
Editorial
Comment